Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Total Non-Current Liabilities (2017 - 2025)

Historic Total Non-Current Liabilities for Pharma-Bio Serv (PBSV) over the last 10 years, with Q3 2025 value amounting to $1.7 million.

  • Pharma-Bio Serv's Total Non-Current Liabilities changed N/A to $1.7 million in Q3 2025 from the same period last year, while for Jul 2025 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Pharma-Bio Serv's Total Non-Current Liabilities is $1.7 million.
  • In the past 5 years, Pharma-Bio Serv's Total Non-Current Liabilities registered a high of $8.9 million during Q1 2021, and its lowest value of $1.7 million during Q3 2025.
  • In the last 5 years, Pharma-Bio Serv's Total Non-Current Liabilities had a median value of $4.2 million in 2022 and averaged $3.9 million.
  • In the last 5 years, Pharma-Bio Serv's Total Non-Current Liabilities soared by 7742.02% in 2021 and then tumbled by 5080.84% in 2022.
  • Pharma-Bio Serv's Total Non-Current Liabilities (Quarter) stood at $5.0 million in 2021, then plummeted by 50.81% to $2.5 million in 2022, then rose by 9.34% to $2.7 million in 2023, then dropped by 28.6% to $1.9 million in 2024, then dropped by 13.42% to $1.7 million in 2025.
  • Its Total Non-Current Liabilities was $1.7 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.9 million in Q4 2024.